))
“Cambrian Explosion of Radiotracers”: In Conversation With Sam and Sean From RefleXion
Manage episode 430521286 series 3334771
Sisällön tarjoaa The Accelerators. The Accelerators tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
The Accelerators (Drs. Matt Spraker and Simul Parikh) host Sam Mazin, Ph.D. and Sean Shirvani, MD, CTO and CMO of RefleXion. This Rad Onc startup have created a linear accelerator with on board PET/CT. This allows for SCINTIX biology-guided radiotherapy for bone and lung disease.
Sam and Sean join the show to share their story in medical entrepreneurship, discuss the technology, and their vision for the future of our field.
Why is SCINTIX any better than fusing a PET/CT to a standard CT simulation?
PET/CT on board and in real time offers potential safety advantages and opportunities for personalized therapy.
Many would argue that novel radio-molecules and total metastatic ablation are the future of our field. Sam and Sean invite us to think bigger and a lot more creatively about how that future might look for our patients.
Here are some other things that were discussed during the show.
- Bob Timmerman and Nina Sanford on TAP, Parts 1 and 2
- RefleXion Research Program Information
- Shankar Siva and others with a good discussion about total metastatic ablation, X
- SCINTIX receives FDA clearance, RefleXion
84 jaksoa
Jaa
